Catheter ablation of atrial fibrillation in the elderly

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 8, 2009, Pages 1085-1091

  Yamada, Takumi ^a   Kay, G Neal ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Elderly; Quality of life; Rhythm control

Indexed keywords

ANTIARRHYTHMIC AGENT; DRONEDARONE; PLACEBO; WARFARIN;

ANTICOAGULATION; BLEEDING; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DRUG WITHDRAWAL; FEASIBILITY STUDY; GROUPS BY AGE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART PACING; HEART RHYTHM; HEART TAMPONADE; HEMATOTHORAX; HIGH RISK PATIENT; HUMAN; LUNG VEIN OBSTRUCTION; MORBIDITY; MORTALITY; POPULATION; QUALITY OF LIFE; REVIEW; RISK; SAFETY; SCORING SYSTEM; THERAPY EFFECT; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS;

EID: 68449102604     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02442.x     Document Type: Review

References (47)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al., American College of Cardiology /American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e257 e354.
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995 155 : 469 473.
3. Aronow W. Management of the older person with atrial fibrillation. J Gerontol 2002 57A : M352 M363.
4. Go A, Hylek E, Phillips K, Chang Y, Henault L, Selby J, Singer D. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001 285 : 2370 2375.
5. Stewart S, Hart CL, Hole DJ, McMurray JJV. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002 113 : 359 364.
6. Kannel W, Abbott R, Savage D, McNamara P. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982 306 : 1018 1022.
7. Rathore S, Berger A, Weinfurt K, Shulman K, Oetgen W, Gersh B, Solomon A. Acute myocardial infarction complicated by atrial fibrillation in the elderly. Circulation 2000 101 : 969 974.
8. Prystowsky E. Assessment of rhythm and rate control in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2006 17 (Suppl 2 S7 S10.
9. Hurwitz JL. Atrial fibrillation treatment in the elderly: Are we getting closer to an answer? J Cardiovasc Electrophysiol 2008 19 : 812 814.
10. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, et al., Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.
11. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, et al., AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004 109 : 1509 1513.
12. Coletta AP, Cleland JG, Cullington D, Clark AL. Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452. Eur J Heart Fail 2008 10 : 917 920.
13. Oral H, Hall B, Chugh A, Cheung P, Lemola K, Good E, Tamirisa K, et al., Age and catheter ablation for atrial fibrillation. Circulation 2004 110 (Suppl Abstract)
14. Hsieh M, Tai Lee S, Tsao H, Lin Y, Huang J, Chan P, Chen Y, et al. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2005 19 : 457 461.
15. Hsu LF, Jaïs P, Sanders P, Hocini M, Sacher F, Takahashi Y, Rotter M, et al. Catheter ablation of permanent atrial fibrillation in the elderly. Heart Rhythm 2005 2 (Suppl 1S P664 Abstract)
16. Zado E, Callans DJ, Riley M, Hutchinson M, Garcia F, Bala R, Lin D, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 2008 19 : 621 626.
17. Corrado A, Patel D, Riedlbauchova L, Fahmy T, Themistoclakis S, Bonso A, Rossillo A, et al. Efficacy, safety and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol 2008 19 : 807 811.
18. Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A, Henrikson CA, et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol 2008 19 : 627 631.
19. Curtis AB, Rich MW. Atrial fibrillation in the elderly: Mechanisms and management. Heart Rhythm 2007 4 : 1577 1579.
20. Packer DL, Asirvatham S, Munger TM. Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol 2003 14 (Suppl S296 309.
21. Bhargava M, Marrouche N, Martin D, Schweikert R, Saliba W, Saad E, Bash D, et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter: A retrospective analysis. J Cardiovasc Electrophysiol 2004 15 : 8 13.
22. Kok LC, Mangrum MJ, Haines DE, Mounsey JP. Cerebrovascular complications associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002 13 : 764 767.
23. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998 2 : 121 135.
24. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: A randomized controlled study. Circulation 1997 96 : 2617 2624.
25. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: A meta-analysis. Circulation 2000 101 : 1138 1144.
26. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001 344 : 1043 1051.
27. Hsieh MH, Tai CT, Lee SH, Tsao HM, Lin YK, Huang JL, Chan P, et al. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2005 16 : 457 461.
28. Dagres N, Piorkowski C, Kottkamp H, Kremastinos DT, Hindricks G. Contemporary catheter ablation of arrhythmias in geriatric patients: Patient characteristics, distribution of arrhythmias, and outcome. Europace 2007 9 : 477 480.
29. Cappato R, Calkins H, Chen S-A, Davies W, Iesaka Y, Kalman J, Kim Y-H, et al. Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation 2005 111 : 1100 1105. (Pubitemid 40365469)
30. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr., et al., Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007 4 : 816 861. (Pubitemid 46850611)
31. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003 42 : 185 197.
32. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991 2 : 983 988.
33. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists. Circulation 1999 99 : 3028 3035.
34. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-up study. Am J Med 1995 98 : 476 484.
35. Wolf PA, Dawber TR, Thomas HE, Thomas HE Jr., Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978 28 : 973 977.
36. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999 131 : 492 501.
37. The Stroke Prevention in Atrial Fibrillation Investigators. Results of the Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994 343 : 687 691.
38. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994 120 : 897 902.
39. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006 114 : 759 765.
40. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001 285 : 2864 2870.
41. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005 112 : 307 313.
42. Mainigi SK, Sauer WH, Cooper JM, Dixit S, Gerstenfeld EP, Callans DJ, Russo AM, et al. Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol 2007 18 : 69 74.
43. Levy S. Factors predisposing to the development of atrial fibrillation. Pacing Clin Electrophysiol 1997 20 : 2670 2674.
44. Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999 341 : 857 865.
45. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004 351 : 2373 2383.
46. Goldberg A, Menen M, Mickelsen S, MacIndoe C, Binder M, Nawman R, West G, et al. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J Interv Card Electrophysiol 2003 8 : 59 64.
47. Chan PS, Vijan S, Morady F, Oral H. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol 2006 47 : 2513 2520. (Pubitemid 43866357)